NSECopy of Newspaper Publication3d ago · 3 Aug 2026, 07:19 pm
Copy of Newspaper Publication
Aarti Drugs Limited · AARTIDRUGS
✦ AI SummaryResults
Aarti Drugs Limited has published its standalone and consolidated financial results for the quarter ended June 30, 2026, in accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication
Attachments (1)
📄pdf
Download →
AARTIDRUGS_03082026191930_ADL.pdf
View document text
Ref: ADL/SE/2026-27/33
August 3, 2026
To, To,
Listing/ Compliance Department Listing/ Compliance Department
BSE Limited National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1,
Dalal Street, G Block Bandra - Kurla Complex,
Mumbai – 400 001
Bandra (East), Mumbai – 400051
BSE CODE: 524348
NSE SYMBOL: AARTIDRUGS
Dear Sir/Madam,
Ref: Regulation 47 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Sub: Newspaper Publication of Financial Results
In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 please find enclosed herewith newspaper
publication of Standalone and Consolidated Financial Results for the Quarter ended
June 30, 2026, published in the following newspapers on Sunday, August 2, 2026:
1) Financial Express (English)
2) Pratahkal (Marathi)
Plesda
Kindly take the same on record.
Thanking you,
Yours faithfully,
FOR AARTI DRUGS LIMITED
RUSHIKESH DEOLE
COMPANY SECRETARY & COMPLIANCE OFFICER
ICSI M. No.: F12932
Published in Financial Express (English) on Sunday i.e. August 2, 2026
Published in Pratahkal (Marathi) on Sunday i.e. August 2, 2026